Human Monkeypox Research

Dear Colleagues,

Monkeypox virus is a zoonotic orthopox DNA virus whose symptoms are similar to smallpox, was first described in humans in 1970 in the Democratic Republic of Congo, in a 9-month-old boy. Since the early May 2022, there have been more than 3000 monkeypox infections in more than 50 countries over the world. WHO claimed that monkeypox is becoming an “evolving threat of moderate public health concern”.

If the global transmission of monkeypox is as the SARS-CoV-2 in the past two years. It will make us drawn into another global crisis. In this case, it is extremely urgent to prevent the continuing spread of monkeypox infection. Currently, an antiviral agent developed for the treatment of smallpox has been licensed for the treatment of monkeypox.

This topic, together with journals (Viruses, Pathogens, Tropical Medicine and Infectious Disease, Diseases, Infectious Disease Reports), provide a platform for researchers around the globe to share the novel and cutting-edge works about human monkeypox. We welcome, to receive, original research, reviews, short communications, comments, perspectives, case reports on the basis of human monkeypox virus and the diagnosis, treatment and prevention.

Prof. Dr. Shailendra K. Saxena
Prof. Dr. Ahmed Sayed Abdel-Moneim
Topic Editors